Odyssey Therapeutics, Inc. (ODTX) stock
ODTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026
$18.98−0.39 (-2.01%)
Close on Nov 18, 2026Market cap $912.15MP/E –Yield –
Odyssey Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Odyssey Therapeutics's market cap was $1.01B on Nov 11, 2026.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $1.01B | – |
See a number that looks wrong?